Researchers have discovered that certain drugs utilized for treating ADHD (Attention Deficit Hyperactivity Disorder) could assist while dealing with the symptoms of Alzheimer’s. In a recent study, researchers assessed how noradrenergic drugs used in ADHD patients could also be utilized for treating Alzheimer’s. These drugs target the noradrenergic system, which possesses locus coeruleus, a small portion of the brainstem.

This area is accountable for various functions that involve learning, attention, and memory. It is regulated by a neurotransmitter known as noradrenaline, a unique type of brain cell that sends and receives messages in the brain. It is also involved in our body’s “flight or fight response.”

Alongside Alzheimer’s, other diseases such as ADHD, depression, and anxiety also lead to issues with the noradrenergic system functions. Noradrenergic treatments are therefore prescribed for these diseases as well.

During the study, researchers performed 19 studies and scanned through the data of more than 1,800 patients. They furthermore explored the different kinds of drugs like those used for ADHD and depression. They discovered that the drugs helped to enhance the thinking and understanding of people suffering from Alzheimer’s. However, they were not useful in improving the performance of specific memory functions, executive functions, visuospatial abilities, or agitation.

The drugs proved beneficial in enhancing the lack of interest, a common symptom in people with Alzheimer’s, and can influence their quality of life and brain function.

The study inferred that noradrenergic drugs could be utilized for treating symptoms in a few patients with Alzheimer’s, provided that the right dosage is used.

Previous article‘Nothing Phone 1’ Could Be Released Without an Included Charger, Retail Packaging Suggests
Next articleTwitter Hire Top Law Firm to Sue Elon Musk For Cancelling His $44 Billion Takeover
Alice is the Chief Editor with relevant experience of three years, Alice has founded Galaxy Reporters. She has a keen interest in the field of science. She is the pillar behind the in-depth coverages of Science news. She has written several papers and high-level documentation.


Please enter your comment!
Please enter your name here